登录 | 注册    关注公众号  
微信公众号
搜索
 > 【ADAMTS5】

ADAMTS5信息

英文名称:ADAMTS5
中文名称:血小板结合蛋白基序的解聚蛋白样金属蛋白酶-5
靶点别称
上市药物数量:0
临床药物数量:2
最高研发阶段:临床二期

ADAMTS5产品咨询

* 此表格只用于收集产品需求咨询,所有信息将严格保密。
                   
ACRO质量管理体系
 
评论(0)
 

ADAMTS5 分子别名

ADAM-TS 5, ADAM-TS5, ADAMTS-5, ADAM-TS 11, ADAMTS-11, ADMP-2, ADAMTS11, ADMP2, Aggrecanase-2

ADAMTS5 分子背景

Members of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family are known to influence development, angiogenesis, coagulation and progression of arthritis. ADAMTS levels and activities are regulated at multiple levels through the control of gene expression, mRNA splicing, protein processing and inhibition by TIMP (tissue inhibitor of metalloproteinases). A recent screen of human cartilage has shown that multiple members of the ADAMTS family may be important in connective tissue homeostasis and pathology. ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5), also known as aggrecanase-2 and ADAMTS11, is a member of the family of secreted zinc proteases with a multi-domain structure.

ADAMTS5 前沿进展

ADAMTS5临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定